Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies
- PMID: 31240885
- PMCID: PMC6660329
- DOI: 10.3343/alm.2019.39.6.566
Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies
Abstract
ELISAs and rapid diagnostic tests (RDTs) are widely used for diagnosing dengue virus (DENV) infection. Using 138 single blood samples, we compared the ability to detect non-structural (NS)-1 antigen and anti-DENV IgM/IgG antibodies among (1) DENV Detect NS1 ELISA, DENV Detect IgM capture ELISA and DENV Detect IgG ELISA (InBios International, Inc.); (2) Anti-Dengue virus IgM Human ELISA and Anti-Dengue virus IgG Human ELISA (Abcam); (3) Dengue virus NS1 ELISA, Anti-Dengue virus ELISA (IgM) and Anti-Dengue virus ELISA (IgG) (Euroimmun); (4) Asan Easy Test Dengue NS1 Ag 100 and Asan Easy Test Dengue IgG/IgM (Asan Pharm); (5) SD BIOLINE Dengue Duo (Standard Diagnostics); and (6) Ichroma Dengue NS1 and Ichroma Dengue IgG/IgM (Boditech Med). For NS1 antigen detection, InBios and Euroimmun showed higher sensitivities (100%) than the RDTs (42.9-64.3%). All tests demonstrated variable sensitivities for IgM (38.1-90.5%) and IgG (65.7-100.0%). InBios and Boditech Med demonstrated higher sensitivity (95.6% and 88.2%, respectively) than the other tests for combined NS1 antigen and IgM antibody. Five NS1 antigen tests had good agreement (92.8-98.6%) without showing positivity for chikungunya. However, all IgG tests demonstrated potential false-positivity with variable ranges. Clinical laboratories should note performance variations across tests and potential cross-reactivity.
Keywords: Dengue virus; Diagnosis; ELISA; Performance; Rapid diagnostic tests.
© The Korean Society for Laboratory Medicine.
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Similar articles
-
Assessment of diagnostic and analytic performance of the SD Bioline Dengue Duo test for dengue virus (DENV) infections in an endemic area (Savannakhet province, Lao People's Democratic Republic).PLoS One. 2020 Mar 17;15(3):e0230337. doi: 10.1371/journal.pone.0230337. eCollection 2020. PLoS One. 2020. PMID: 32182271 Free PMC article.
-
Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India.Indian J Med Res. 2020 Jan;151(1):71-78. doi: 10.4103/ijmr.IJMR_613_18. Indian J Med Res. 2020. PMID: 32134017 Free PMC article.
-
Serodiagnosis of dengue virus infection using commercially available antibody and NS1 antigen ELISAs.Diagn Microbiol Infect Dis. 2017 Jun;88(2):120-124. doi: 10.1016/j.diagmicrobio.2017.03.015. Epub 2017 Mar 30. Diagn Microbiol Infect Dis. 2017. PMID: 28389145
-
Dengue Detection: Advances in Diagnostic Tools from Conventional Technology to Point of Care.Biosensors (Basel). 2021 Jun 23;11(7):206. doi: 10.3390/bios11070206. Biosensors (Basel). 2021. PMID: 34201849 Free PMC article. Review.
-
Association of dengue virus non-structural-1 protein with disease severity: a brief review.Trans R Soc Trop Med Hyg. 2022 Nov 1;116(11):986-995. doi: 10.1093/trstmh/trac087. Trans R Soc Trop Med Hyg. 2022. PMID: 36125197 Review.
Cited by
-
Performance of VIDAS® Diagnostic Tests for the Automated Detection of Dengue Virus NS1 Antigen and of Anti-Dengue Virus IgM and IgG Antibodies: A Multicentre, International Study.Diagnostics (Basel). 2023 Mar 16;13(6):1137. doi: 10.3390/diagnostics13061137. Diagnostics (Basel). 2023. PMID: 36980445 Free PMC article.
-
Performance of a New Microfluidic Dengue NS1 Immuno-magnetic Agglutination Assay for the Rapid Diagnosis of Dengue Infection in Adults.Am J Trop Med Hyg. 2021 Jul 19;105(3):771-776. doi: 10.4269/ajtmh.20-1558. Am J Trop Med Hyg. 2021. PMID: 34280136 Free PMC article.
-
Coinfection and cross-reaction of dengue and COVID-19: a case series analysis.Rev Soc Bras Med Trop. 2022 Oct 21;55:e02432022. doi: 10.1590/0037-8682-0243-2022. eCollection 2022. Rev Soc Bras Med Trop. 2022. PMID: 36287508 Free PMC article.
-
Diagnostic Performance of Dengue NS1 and Antibodies by Serum Concentration Technique.Trop Med Infect Dis. 2023 Feb 14;8(2):117. doi: 10.3390/tropicalmed8020117. Trop Med Infect Dis. 2023. PMID: 36828533 Free PMC article.
-
A systematic review and meta-analysis on the accuracy of rapid immunochromatographic tests for dengue diagnosis.Eur J Clin Microbiol Infect Dis. 2022 Sep;41(9):1191-1201. doi: 10.1007/s10096-022-04485-6. Epub 2022 Aug 20. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35988010
References
-
- World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control: new edition. World Health Organization; 2009. [Updated on Jan 2009]. http://www.who.int/iris/handle/10665/44188. - PubMed
-
- Blacksell SD, Jarman RG, Bailey MS, Tanganuchitcharnchai A, Jenjaroen K, Gibbons RV, et al. Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy. Clin Vaccine Immunol. 2011;18:2095–2101. - PMC - PubMed
-
- Fatima A, Wang J. Review: progress in the diagnosis of dengue virus infections and importance of point of care test: a review. Pak J Pharm Sci. 2015;28:271–280. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous